Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 0.1926 Delayed Data As of Mar 24 |  +0.0006 / +0.31%Today’s Change | 0.17 Today|||52-Week Range 1.76 | -65.30% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $17.4M |
Company Description
Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development segment. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.
Contact Information
Infinity Pharmaceuticals, Inc. 1100 Massachusetts Avenue Cambridge Massachusetts 02138 |
Employees
Shareholders
| Individual stakeholders | 22.53% |
| Other institutional | 19.15% |
| Mutual fund holders | 11.12% |
Top Executives
| Adelene Q. Perkins | Chairman & Chief Executive Officer |
| Lawrence E. Bloch | President & Treasurer |
| Melissa Hackel | Vice President-Finance |
| Stephane Peluso | Chief Scientific Officer |
| Robert Ilaria | Chief Medical Officer |
